1 . Zhao J, Yuan Q, Wang H, Liu w, Liao X, Su Y, et al.. "Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019" . the Infectious Diseases Society of America. 2020Nov19; 71(16):2027–2034. PMID: 32221519

2 . Lu H, Stratton CW, Tang YW. "Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle" . Journal of medical virology. 2020; 92(4):401–402. PMID: 31950516

3 . World Health Organisation. "WHO Director-General's statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV)IHR Emergency Committee on Novel Coronavirus (2019-nCoV)" . 2020January.

4 . Gorbalenya AE, Baker S, Baric R, de Groot R J, Drosten C, Gulyaeva A, et al.. "The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2" . Nature microbiology. 2020; 5(4):536–544.

5 . "COVID-19.cdc.gov.sa. Public Health Authority" . c2021. Available from: https://COVID-1919.cdc.gov.sa/daily-updates/

6 . World health organisation. "Statement – Older People Are at Highest Risk from COVID-19, but All Must Act to Prevent Community Spread" . 2020April.

7 . Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L, et al.. "COVID-19 in hemodialysis (HD) patients: Report from one HD center in Wuhan, China" . medRxiv. January2020:2020.02.24.20027201.

8 . Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al.. "Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study" . BMJ (Clinical research ed). 2020; 368:m1091. PMID: 32217556.

9 . Kliger AS, Cozzolino M, Jha V, Harbert G, Ikizler TA. "Managing the COVID-19 pandemic: international comparisons in dialysis patients" . Kidney international. 2020; 98(1):12–16. PMID: 32471637.

10 . Cheng Y, Luo R, Wang K, Wang K, Zhang M, Wong Z, et al.. "Kidney disease is associated with in-hospital death of patients with COVID-19" . Kidney international. 2020; 97(5):829–838. PMID: 32247631.

11 . Goicoechea M, Sánchez Cámara LA, Macías N, Morales AM, Rojas AG, Bascuñana A, et al.. "COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain" . Kidney international. 2020; 98(1):27–34. PMID: 32437770.

12 . Lee JJ, Lin CY, Chiu YW, Hwang SJ. "Take proactive measures for the pandemic COVID-19 infection in the dialysis facilities" . Journal of the Formosan Medical Association = Taiwan yi zhi. 2020; 119(5):895–897. PMID: 32291136.

13 . Clarke C, Prendecki M, Dhutia A, Ali MA, Sajjad H, Shivakumaro O, et al.. "High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening" . Journal of the American Society of Nephrology: JASN. 2020; 31(9):1969–1975. PMID: 32732391.

14 . Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, et al.. "Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis" . Journal of medical virology. 2020; 92(9):1518–1524. PMID: 32104917.

15 . Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F, et al.. "Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)" . Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2020; 71(15):778–785. PMID: 32198501.

16 . Mahallawi WH, Al-Zalabani AH. "The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia" . Saudi journal of biological sciences. 2021; 28(3):1697–1701. PMID: 33519277.

17 . Alharbi NK, Alghnam S, Algaissi A, Albalawi H, Alenazi MW, Albargawi AM, et al.. "Nationwide Seroprevalence of SARS-CoV-2 in Saudi Arabia" . Journal of infection and public health. 2021; 14(7):832–838. PMID: 34118732.

18 . Lawrence MFriedman Curt DFurberg-David LDe Mets David MReboussin Christopher B. "Granger" . Fundamentals of Clinical Trials. fifth edit.; 2015. Springer; 2015.

19 . " Smartsheet.com [Internet]. Smratsheet" . c2021. Available from: https://www.smart-sheet.com.

20 . Wickens O, Chinnadurai R, Mannan F, Svendsen F, Baig MY, Chukwu C, et al.. "Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom" . BMC nephrology. 2021; 22(1):154. PMID: 33902482.

21 . Sakhi H, Dahmane D, Attias P, Kofman T, Bouvier M, Lapidus N, et al.. "Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection" . Journal of the American Society of Nephrology: JASN. 2021; 32(5):1033–1036. PMID: 33637518.

22 . Alserehi HA, Alqunaibet AM, Al-Tawfiq JA, Alharbi NK, Alshukairi AN, Alanazi KH, et al.. "Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals" . Diagnostic microbiology and infectious disease. 2021; 99(3):115273. PMID: 33296851.

23 . Banjar A, Al-Tawfiq JA, Alruwaily A, Alruwaily A, Alserehi H, Al-Qunaibet A, Alas-wad R, et al.. "Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia" . International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2021; 104:452–457. PMID: 33465488.